Oxandrolone in Healthy Adults: A Relative Bioavailability Study

Completed · Phase 1

Conditions studied: Bioavailability

In brief

To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small cohort of healthy adults.

Key facts

Study ID

NCT03218631

Run by

University of Utah

People needed

6

Starts

2017-07-10

Expected to finish

2017-11-30

Last updated by the study team

2018-05-03

Who can join

Age: 18 and older, up to 35. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Male
• Age 18 to 35 years (inclusive) at the time of screening
• Body mass index [BMI, body weight (kg)/height (m)2] below 30 kg/m2
• Medically healthy

You may not qualify if…

• Known allergy to anabolic steroids
• Use of any prescription medication currently or within 14 days prior to dosing
• Use of tobacco or nicotine containing products (including smoking cessation products), within 6 months prior to dosing
• Any chronic medical condition
• Seated blood pressure <90/40 mmHg or >140/90 mmHg at screening
• Heart rate <40 or >99 at screening
• Subjects who have taken any investigational drug within 30 days prior to first dose in the current study

Where it is running

• Primary Children's Hospital — Salt Lake City, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.